Findings of Misconduct by a then Drug Enforcement Administration Regional Director for Misuse of Sensitive Investigative Unit Funds, Misuse of Representation Funds, Lack of Candor in Request for Representation Funds, and Related Misconduct
- NARA ID
- findings-misconduct-then-drug-enforcement-administration-regional-director-misuse-sensitive
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Investigation
- Released
- 2023-01-25
- Slug
- doj-oig-findings-misconduct-then-drug-enforcement-administration-regional-director-misuse-sensitive
- Indexed
- 2026-04-27 05:02:03
More from DOJ OIG — Drug Enforcement Administration
- Review of the Organized Crime Drug Enforcement Task Forces Fusion Center
- Audit of the Drug Enforcement Administration's Spider Core System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2021
- Audit of the Drug Enforcement Administration’s El Paso Intelligence Center Seizure System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2024
- Review of the Drug Enforcement Administration's Accounting of Drug Control Funding Fiscal Year 2024
- Audit of the Drug Enforcement Administration’s Headquarters-Based Oversight of its Supported Foreign Law Enforcement Units
- Report of Investigation of the Actions of Former DEA Leadership in Connection with the Reinstatement of a Security Clearance
Browse all 56 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.